Clinical significance of signs of autoimmune colitis in 18F-fluorodeoxyglucose positron emission tomography-computed tomography of 100 stage-IV melanoma patients
出版年份 2019 全文链接
标题
Clinical significance of signs of autoimmune colitis in 18F-fluorodeoxyglucose positron emission tomography-computed tomography of 100 stage-IV melanoma patients
作者
关键词
-
出版物
Immunotherapy
Volume 11, Issue 8, Pages 667-676
出版商
Future Medicine Ltd
发表日期
2019-05-15
DOI
10.2217/imt-2018-0146
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma
- (2018) Alexander T. Faje et al. CANCER
- Longitudinal studies of the 18F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT
- (2018) Christos Sachpekidis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- “No pain, No gain” still true with immunotherapy: When the finger shows the moon, look at the moon!
- (2018) G. Milano et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma
- (2018) Christos Sachpekidis et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients
- (2018) Michael Constantin Kirchberger et al. Oncotarget
- Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond
- (2018) Kristina Buder-Bakhaya et al. Frontiers in Immunology
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions
- (2018) Ulrike W Kaunzner et al. BRAIN
- Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab
- (2017) Hoda Anwar et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy
- (2017) Annie N. M. Wong et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab-Induced Gastrointestinal Toxicities: A Management Algorithm
- (2016) Jagpal S. Klair et al. DIGESTIVE DISEASES AND SCIENCES
- Survival of patients with advanced metastatic melanoma: The impact of novel therapies
- (2016) Selma Ugurel et al. EUROPEAN JOURNAL OF CANCER
- Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
- (2016) Krista Dubin et al. Nature Communications
- Fractal and multifractal analysis of PET/CT images of metastatic melanoma before and after treatment with ipilimumab
- (2016) Christina-Marina Breki et al. EJNMMI Research
- Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
- (2015) Anne Bertrand et al. BMC Medicine
- Pancreatitis Secondary to Anti–Programmed Death Receptor 1 Immunotherapy Diagnosed by FDG PET/CT
- (2015) Yazan Z. Alabed et al. CLINICAL NUCLEAR MEDICINE
- Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
- (2015) Hansje-Eva Teulings et al. JOURNAL OF CLINICAL ONCOLOGY
- PET/CT, MR, and PET/MR in Lymphoma and Melanoma
- (2015) Nina F. Schwenzer et al. SEMINARS IN NUCLEAR MEDICINE
- Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab
- (2015) S. H. Tirumani et al. Cancer Immunology Research
- Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study
- (2014) Christos Sachpekidis et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme
- (2013) Anna Maria Di Giacomo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Ipilimumab-Induced Colitis on FDG PET/CT
- (2012) Ashima Lyall et al. CLINICAL NUCLEAR MEDICINE
- Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
- (2012) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiologic Manifestations of Immune-Related Adverse Events in Patients With Metastatic Melanoma Undergoing Anti–CTLA-4 Antibody Therapy
- (2011) Yulia Bronstein et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- 18F-FDG PET/CT imaging of an anti-CTLA-4 antibody-associated autoimmune pancolitis
- (2011) Lode Goethals et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started